Edition:
United States

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

3.93USD
3:14pm EST
Change (% chg)

$0.05 (+1.29%)
Prev Close
$3.88
Open
$3.83
Day's High
$3.96
Day's Low
$3.83
Volume
13,610
Avg. Vol
21,370
52-wk High
$8.55
52-wk Low
$3.37

Chart for

About

Cidara Therapeutics, Inc., formerly K2 Therapeutics, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery, development and commercialization of anti-infectives. It is developing a pipeline of product and development candidates with a focus on serious fungal infections. Its product portfolio... (more)

Overall

Beta: 1.84
Market Cap(Mil.): $107.68
Shares Outstanding(Mil.): 27.75
Dividend: --
Yield (%): --

Financials

  CDTX.OQ Industry Sector
P/E (TTM): -- 79.62 29.34
EPS (TTM): -3.11 -- --
ROI: -87.06 -0.41 13.58
ROE: -116.89 -3.13 15.11

BRIEF-Cidara Announces Stock And Warrants Offering Worth $120 Mln

* CIDARA THERAPEUTICS ANNOUNCES OFFERING OF COMMON STOCK AND WARRANTS

May 21 2018

BRIEF-Cidara Therapeutics Files For Stock Shelf Of Up To $10 Mln

* CIDARA THERAPEUTICS INC FILES FOR STOCK SHELF OF UP TO $10 MILLION – SEC FILING Source text (https://bit.ly/2kebUqL) Further company coverage:

May 21 2018

Earnings vs. Estimates